Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Weave Communications M&A Deal with Francisco Partners Management, L.P.
Weave Communications received early termination of the HSR Act waiting period for its pending acquisition by affiliates of Francisco Partners. This regulatory milestone satisfies a key closing condition for the merger, which was originally announced on August 18, 2026. The transaction is currently expected to close in the fourth quarter of 2026, subject to stockholder approval.
Construction Partners M&A Deal with Roads, Inc. of NWF
Construction Partners, Inc. (CPI) has completed the acquisition of Roads, Inc. of NWF, an asphalt manufacturing and construction business based in Cantonment, Florida. The deal includes a hot-mix asphalt plant north of Pensacola and adds more than 150 employees to CPI's Florida platform, C.W. Roberts Contracting. The acquisition is intended to expand the company's service capabilities and geographic footprint in the Florida Panhandle.
Orion180 Insurance Group Inc. completed its initial public offering (IPO) of 20,000,000 shares of Class A common stock at a price of $12.00 per share. The offering generated gross proceeds of $240.0 million and coincided with the appointment of five new directors to the company's board.
PTC Therapeutics M&A Deal with Sangamo Therapeutics, Inc.
PTC Therapeutics has completed its acquisition of ST-920 (isaralgagene civaparvovec), a BLA-stage AAV gene therapy for Fabry disease, from Sangamo Therapeutics. The company expects to complete a rolling Biologics License Application (BLA) submission to the FDA for accelerated approval in the fourth quarter of 2026. The acquisition adds a potential one-time treatment for Fabry disease to PTC's rare disorder pipeline.
PennantPark Private Income Fund Capital Raise of $830K
PennantPark Private Income Fund issued and sold 32,047 common shares for aggregate proceeds of approximately $830,000. The sale was conducted as part of the company's ongoing continuous private offering to accredited investors.
Calisa Acquisition M&A Deal with Goodvision AI Inc.
Calisa Acquisition Corp entered into a Prepaid Forward Purchase Agreement with Goodvision AI Inc. and Harraden Circle Investments to support its pending business combination. Under the agreement, the purchaser may acquire up to 3,000,000 ordinary shares to minimize redemptions and maximize cash retention upon the closing of the merger.
BioCardia has regained compliance with Nasdaq's $1.00 minimum bid price requirement after its common stock closed at or above $1.00 per share for at least 10 consecutive business days. The company had previously received a deficiency notice on August 19, 2026, and Nasdaq has now officially closed the matter. The company's common stock will continue to trade on The Nasdaq Capital Market under the symbol 'BCDA'.
Isabella Bank M&A Deal with Grand River Commerce, Inc.
Isabella Bank Corporation announced that shareholders of Grand River Commerce, Inc. have approved the previously announced merger agreement between the two companies. The transaction, which involves the merger of Grand River into Isabella and their respective bank subsidiaries, is expected to close in the fourth quarter of 2026 subject to regulatory approvals.
NewAmsterdam Pharma and its partner Menarini Group received European Commission marketing authorization for Ubeslo (obicetrapib) and Evlarco (obicetrapib/ezetimibe FDC) for the treatment of hypercholesterolaemia, marking the first regulatory approval for obicetrapib worldwide. The approval triggers milestone payments to NewAmsterdam in the mid-teens of millions of euros under its existing licensing agreement with Menarini. The company remains eligible for up to €833 million in total milestones plus tiered double-digit royalties on net sales in Europe.
Linkhome Holdings Inc. has regained compliance with Nasdaq's minimum bid price requirement after its common stock maintained a closing bid price of at least $1.00 per share for 10 consecutive business days. The company had previously received a deficiency notice on June 29, 2026, for failing to meet the $1.00 threshold. Nasdaq has officially closed the matter, ensuring the company's continued listing on the Nasdaq Capital Market.
Host Digital Inc. completed an underwritten public offering of 2,187,500 shares of Class A common stock at a price of $8.00 per share, raising approximately $17.5 million in gross proceeds. The company intends to use the net proceeds for data center investments, capital expenditures, and general corporate purposes. Cantor Fitzgerald & Co. acted as the lead book-running manager for the offering.
Visium Technologies Partnership with PT Visium Compute Indonesia
Visium Technologies executed a non-binding term sheet to form a new Indonesian joint venture vehicle, PT Visium Compute Indonesia (PTVCI), to hold assigned contract-use, offtake, and deployment rights for a device design. Visium's subsidiary will hold a 99% equity interest in the new entity, with the transaction structured as an assignment of rights rather than an acquisition of an operating company. Consideration for the deal is expected to consist of a newly designated series of non-voting convertible preferred stock.
Ares Sports, Media & Entertainment Opportunities Capital Raise of $47M
Ares Sports, Media and Entertainment Opportunities LP sold unregistered limited partnership units for approximately $47.0 million as part of its continuous private offering. As of September 21, 2026, the Fund has raised approximately $911 million in aggregate cash consideration through this offering program.
Bunker Hill Mining M&A Deal with Silver47 Exploration Corp.
Bunker Hill Mining Corp. is providing a status update on its pending acquisition of Silver47 Exploration Corp. by filing historical and pro forma financial statements required for the transaction. The filing includes audited financials for Silver47 and Summa Silver Corp. to facilitate the incorporation of the deal into the company's registration statements.
Quanome Technologies entered into a purchase agreement with Compal Electronics to acquire 32 GPU server units for approximately $18.8 million. The company intends to deploy these servers to build out its artificial intelligence computing infrastructure business.
Monroe Capital Income Plus Corp reported an unregistered sale of equity securities under Item 3.02. As a Business Development Company (BDC), this typically represents the issuance of new shares to investors through a private placement or continuous offering.
TransDigm Group Signs $240M M&A Deal with Extant Aerospace / Portfolio of commercial rotorcraft
TransDigm Group's operating unit, Extant Aerospace, has entered into a definitive agreement to acquire a portfolio of commercial rotorcraft, land systems, and business jet products, including a California facility, for approximately $240 million in cash. The acquisition is expected to close during fiscal year 2027, subject to regulatory approvals and customary closing conditions.
Value
$240M
Counterparty
Extant Aerospace (operating unit) / Portfolio of commercial rotorcraft, land systems, and business jet products
GT Biopharma amended its securities purchase agreement to increase a private placement of Series M 10% Convertible Preferred Stock and warrants, raising the aggregate purchase price to $7.75 million. The deal includes 'Greenshoe Rights' allowing purchasers to potentially acquire additional preferred stock with an aggregate stated value of up to approximately $34.7 million. The company has committed to filing a registration statement for the resale of the underlying common stock within 30 days of closing.
Bbcms Mortgage Trust 2026-M1 Capital Raise of $654M
BBCMS Mortgage Trust 2026-M1 entered into agreements to sell $548.3 million in public certificates and $105.4 million in private certificates. The transaction involves the issuance of commercial mortgage pass-through certificates backed by a pool of commercial and multifamily mortgage loans. The closing of the offering is scheduled for September 30, 2026.
Lantheus Holdings M&A Deal with Curium US Holdings LLC
Lantheus Holdings provided a regulatory update on its pending merger with Curium US Holdings LLC, noting that Curium voluntarily withdrew and refiled its HSR Act pre-merger notification to provide the FTC with additional time for review. The new 30-day waiting period is set to expire on October 21, 2026, and the parties still expect to close the transaction in the first half of 2027.
Insight Molecular Diagnostics M&A Deal with Chronix Biomedical, Inc.
Insight Molecular Diagnostics (iMDx) entered into Amendment No. 2 to its merger agreement with Chronix, modifying the earnout structure related to the CNI Monitor technology. The amendment establishes that equity holders will receive a 10% royalty on sales until a potential sale of the technology occurs, at which point they will receive a final payment of 10% of the gross sale proceeds.
Electra Therapeutics closed its initial public offering (IPO) of 23,333,334 shares of common stock at a price of $15.00 per share, generating gross proceeds of approximately $350.0 million. In connection with the closing, the company also filed its amended and restated certificate of incorporation and bylaws.
Sangamo Therapeutics completed the sale of its ST-920 (Fabry disease gene therapy) assets to PTC Therapeutics for $111 million in cash plus up to $100 million in contingent milestones. The sale was conducted via a court-supervised auction process as part of Sangamo's ongoing Chapter 11 bankruptcy proceedings. Additionally, the company's common stock is being formally delisted from Nasdaq effective September 27, 2026.
Barings Private Credit Corporation sold approximately 1.1 million unregistered shares of common stock for $22.0 million in a private placement. The company is conducting a continuous private offering for up to $4.5 billion, having raised over $3 billion to date.
Deep Fission Research Collaboration with Youngquist Brothers, LLC
Deep Fission has entered into a collaboration with Youngquist Brothers to evaluate and test drilling and borehole-construction methods for its underground nuclear reactor deployment model. The partnership leverages Youngquist's expertise in large-diameter drilling to support Deep Fission's strategy of placing small modular reactors one mile underground. The companies recently completed a successful equipment demonstration in Florida involving a 30-inch prototype reactor canister.
Stone Point Credit Income Fund Capital Raise of $12.3M
Stone Point Credit Income Fund issued and sold 498,046.412 common shares to accredited investors for aggregate proceeds of approximately $12.3 million. The shares were sold at a net asset value of $24.6901 per share under private placement exemptions. Since inception, the Fund has received total capital commitments of approximately $1.19 billion, with $776.5 million remaining unfunded.
Dick's Sporting Goods Signs $2.5B M&A Deal with Foot Locker, Inc.
DICK’S Sporting Goods filed pro forma financial information regarding its completed acquisition of Foot Locker, Inc. for approximately $2.5 billion. The deal consideration consisted of $0.2 billion in cash and 9.6 million shares of DICK’S common stock, alongside a $381.9 million debt exchange offer for Foot Locker's senior notes.
Faraday Future Intelligent Electric Product Launch
Faraday Future launched nine new EAI (Embedded AI) device configurations across two robot forms and five models, including the FF All-New Futurist and the FF Master Mini. The company also introduced four Industry Productivity Solutions for sectors such as K-12 education and security, aiming to build a comprehensive 'One-Brain Multi-Form' robotics ecosystem.
Recursion Pharmaceuticals Licensing Deal with Tempus AI, Inc. Worth $12M
Recursion Pharmaceuticals granted Tempus AI a non-exclusive license to its TxFM RNA sequencing model for use in oncology in exchange for a $12 million license fee. Simultaneously, the parties amended an existing master agreement to extend its term to six years and restructure annual license fees, while Recursion gained access to additional de-identified pathology records.
DeFi Development Corp. closed the exercise of an over-allotment option by its underwriter, R.F. Lafferty & Co., Inc., in connection with the IPO of its Variable Rate Series C Perpetual Preferred Stock (CHAD). The exercise resulted in the issuance of 206,250 additional shares for gross proceeds of approximately $1.65 million. The company intends to use the capital to support its strategy of accumulating and compounding Solana (SOL) in its treasury.
Value
$1.65M
Counterparty
R.F. Lafferty & Co., Inc.
“We are firing on all cylinders. We added over $10 million of SOL in just one week and our stock continues to outperform SOL. With CHAD now established as an additional funding engine, we believe we are better positioned than ever to accelerate our treasury growth.”